DexCom Is Pricey For A Reason - Its Growth Story Reflects That [Seeking Alpha]
DexCom, Inc. (DXCM)
Last dexcom, inc. earnings: 4/28 04:03 pm
Check Earnings Report
US:NASDAQ Investor Relations:
dexcom.com/investors
Company Research
Source: Seeking Alpha
The company has demonstrated robust growth in revenue and operating income, warranting its high valuation multiples. DexCom has strong growth catalysts, including the launch of Stelo, which is expected to contribute to significant revenue growth in the future. Investment Thesis DexCom ( NASDAQ: DXCM ) is not exactly every investor's cup of tea. The company operates in the medical technology space, which is far away from the hype in mainstream AI, and yet, the company's stock often confounds investors with its high valuation metrics, per my observation. Rightly so, because 93x trailing twelve-month earnings or 80x forward earnings is often considered expensive. However, I believe investors fail to observe the robust growth DexCom has been able to demonstrate over the past few years and often skip past the ramp it continues to build towards future growth. One of those examples of building ramps is the recent FDA approval that DexCom received for one of its continuous glucose
Show less
Read more
Impact Snapshot
Event Time:
DXCM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DXCM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DXCM alerts
High impacting DexCom, Inc. news events
Weekly update
A roundup of the hottest topics
DXCM
News
- Here's Why DexCom (DXCM) is a Strong Growth Stock [Yahoo! Finance]Yahoo! Finance
- DexCom First Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]Yahoo! Finance
- No Rate Cuts? No Worries. Uncle Sam Has Dough to Disburse. [Yahoo! Finance]Yahoo! Finance
- DexCom, Inc. (NASDAQ: DXCM) had its price target raised by analysts at Raymond James from $151.00 to $160.00. They now have a "strong-buy" rating on the stock.MarketBeat
- DexCom, Inc. (NASDAQ: DXCM) had its price target raised by analysts at Canaccord Genuity Group Inc. from $144.00 to $145.00. They now have a "buy" rating on the stock.MarketBeat
DXCM
Earnings
- 4/25/24 - Beat
DXCM
Sec Filings
- 4/25/24 - Form 10-Q
- 4/25/24 - Form 8-K
- 4/23/24 - Form 144
- DXCM's page on the SEC website